BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chopra A, Nautiyal A, Kalkanis A, Judson MA. Drug-Induced Sarcoidosis-Like Reactions. Chest 2018;154:664-77. [PMID: 29698718 DOI: 10.1016/j.chest.2018.03.056] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
Number Citing Articles
1 Ince B, Kultur E, Sayilir S, Kucukakkas O. Sarcoidosis with axial spondyloarthritis: A case‐based review of simultaneous occurrence. Int J of Rheum Dis 2022;25:1450-1453. [DOI: 10.1111/1756-185x.14453] [Reference Citation Analysis]
2 Garret M, Pestronk A. Sarcoidosis, granulomas and myopathy syndromes: A clinical-pathology review. Journal of Neuroimmunology 2022;373:577975. [DOI: 10.1016/j.jneuroim.2022.577975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kalkanis A, Papadopoulos D, Testelmans D, Kopitopoulou A, Boeykens E, Wauters E. Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer. Diagnostics 2022;12:2949. [DOI: 10.3390/diagnostics12122949] [Reference Citation Analysis]
4 Régis C, Benali K, Rouzet F. FDG PET/CT imaging of sarcoidosis. Seminars in Nuclear Medicine 2022. [DOI: 10.1053/j.semnuclmed.2022.08.004] [Reference Citation Analysis]
5 Albarrán-artahona V, Laguna J, Gorría T, Torres-jiménez J, Pascal M, Mezquita L. Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy. Diagnostics 2022;12:2091. [DOI: 10.3390/diagnostics12092091] [Reference Citation Analysis]
6 Numakura T, Murakami K, Tamada T, Yamaguchi C, Inoue C, Ohkouchi S, Tode N, Sano H, Aizawa H, Sato K, Mitsune A, Kurosawa H, Nakazawa T, Sugiura H. A Novel Development of Sarcoidosis following COVID-19 Vaccination and a Literature Review. Intern Med 2022. [PMID: 35945009 DOI: 10.2169/internalmedicine.0104-22] [Reference Citation Analysis]
7 Mücke MM, Rohde GGU, Zeuzem S. Sarkoidose. Gastroenterologie 2022;17:318-324. [DOI: 10.1007/s11377-022-00642-7] [Reference Citation Analysis]
8 Pantarotto M, Barata R, Coelho R, Carvalheiro C, Rolim I, Garrido P, Gil N, Duarte-ramos F, Stumpf Tonin FS. The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression. Cureus 2022. [DOI: 10.7759/cureus.26729] [Reference Citation Analysis]
9 Ben Salem C. A Review of the Diagnosis and Treatment of Pulmonary Sarcoidosis. JAMA 2022;328:77-8. [PMID: 35788801 DOI: 10.1001/jama.2022.7765] [Reference Citation Analysis]
10 Gonçalves Pimenta DA, Meira L, Rolo R, Ferreira L. Sarcoidosis-like reaction secondary to adalimumab treatment in a patient with axial spondyloarthritis. Monaldi Arch Chest Dis 2022. [DOI: 10.4081/monaldi.2022.2343] [Reference Citation Analysis]
11 Tsitos S, Niederauer LC, Albert i Gracenea P, Mueller J, Straube A, Von Baumgarten L. Case Report: Drug-Induced (Neuro) Sarcoidosis-Like Lesion Under IL4 Receptor Blockade With Dupilumab. Front Neurol 2022;13:881144. [DOI: 10.3389/fneur.2022.881144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mutschlechner B, Dertinger S, Offner F, Buck V, Becherer A, Gasser K, Hartmann B, Winder T. Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab. memo 2022;15:169-72. [DOI: 10.1007/s12254-022-00806-9] [Reference Citation Analysis]
13 Judson MA, Tiwari A, Gemoets DE. The Relationship of Obesity and OSA to the Development of Sarcoidosis. Chest 2022. [DOI: 10.1016/j.chest.2022.05.008] [Reference Citation Analysis]
14 Redl A, Stary G. Kutane Sarkoidose – eine granulomatöse Modellerkrankung. hautnah 2022;21:105-116. [DOI: 10.1007/s12326-022-00502-9] [Reference Citation Analysis]
15 Sangoi AR, Maclean F, Mohanty S, Hes O, Daniel R, Lal P, Canete‐portillo S, Magi‐galluzzi C, Cornejo KM, Collins K, Hwang M, Falzarano SM, Feely MM, Dababneh M, Harik L, Tretiakova M, Akgul M, Manucha V, Chan E, Kao C, Siadat F, Arora K, Barkan G, Cheng L, Hirsch M, Lei L, Wasco M, Williamson SR, Acosta AM. Granulomas associated with renal neoplasms: A multi‐institutional clinicopathological study of 111 cases. Histopathology. [DOI: 10.1111/his.14633] [Reference Citation Analysis]
16 James WE, Bonella F. Pulmonary sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10031820] [Reference Citation Analysis]
17 Judson MA, Pastre J, Israël-biet D. The manifestations of rare organ sarcoidosis. Sarcoidosis 2022. [DOI: 10.1183/2312508x.10033320] [Reference Citation Analysis]
18 Hellbach K. Moderne Tumortherapien und ihre pulmonalen Nebenwirkungen. best practice onkologie 2022;17:56-67. [DOI: 10.1007/s11654-021-00360-6] [Reference Citation Analysis]
19 Roman R. Rheumatic side effects of cancer immunotherapy with immune checkpoint inhibitors. Klin Farmakol Farm 2022;35:106-111. [DOI: 10.36290/far.2021.025] [Reference Citation Analysis]
20 Obi ON, Baughman RP. Sarcoidosis. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-12-801238-3.11660-5] [Reference Citation Analysis]
21 Takele RA, Aboulhosn AZ, Pant P, Laflam P. Hypercalcemia and Granulomatous-Like Lesions in a Patient with Melanoma after Treatment with Immunotherapy: Case Report. CRCM 2022;11:188-193. [DOI: 10.4236/crcm.2022.115028] [Reference Citation Analysis]
22 Vis D, Michaud A, Szabo L, Kelly MM, Martin L, Weatherald J. Pulmonary sarcoid-like granulomatosis during etanercept treatment for inflammatory arthritis: A case series and literature review. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2021. [DOI: 10.1080/24745332.2021.1997127] [Reference Citation Analysis]
23 Sridhar S, Kanne JP, Henry TS, Revels JW, Gotway MB, Ketai LH. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem. Radiographics 2021;:210146. [PMID: 34826256 DOI: 10.1148/rg.210146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Shi Y, Li J, Chen M, Liu H, Ma D, Lin Y, Wang M, Xu Y. Sarcoidosis-like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response. Thorac Cancer 2021. [PMID: 34761878 DOI: 10.1111/1759-7714.14228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mohammed N, Zhou RR, Xiong Z. Imaging evaluation of lung cancer treated with PD-1/PD-L1 inhibitors. Br J Radiol 2021;94:20210228. [PMID: 34541867 DOI: 10.1259/bjr.20210228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Anastasopoulou A, Diamantopoulos PT, Skalioti C, Liapis G, Psychogiou E, Ziogas DC, Gogas H. The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature. Ther Adv Med Oncol 2021;13:17588359211047349. [PMID: 34691245 DOI: 10.1177/17588359211047349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Tomioka H. Drug-induced sarcoidosis-like reactions. JJSOGD 2021;41:35-8. [DOI: 10.7878/jjsogd.41.1_2_35] [Reference Citation Analysis]
28 Hellbach K. [Modern tumor therapy and its pulmonary side effects]. Radiologe 2021;61:955-67. [PMID: 34550423 DOI: 10.1007/s00117-021-00912-5] [Reference Citation Analysis]
29 Bernardinello N, Petrarulo S, Balestro E, Cocconcelli E, Veltkamp M, Spagnolo P. Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis. Diagnostics (Basel) 2021;11:1558. [PMID: 34573900 DOI: 10.3390/diagnostics11091558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Chanson N, Ramos-Casals M, Pundole X, Suijkerbuik K, José de Barros E Silva M, Lidar M, Benesova K, Leipe J, Acar-Denizli N, Pradère P, Michot JM, Voisin AL, Suárez-Almazor ME, Radstake TRD, Fernandes Moça Trevisani V, Schulze-Koops H, Melin A, Robert C, Mariette X, Baughman RP, Lambotte O; ICIR., Coordination., Co-Convenors., Steering Committee., Research Fellows., Data Scientist. Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation. Eur J Cancer 2021:S0959-8049(21)00476-7. [PMID: 34452793 DOI: 10.1016/j.ejca.2021.05.041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
31 Cabanié C, Ammari S, Hans S, Pobel C, Laparra A, Danlos FX, Chanson N, Dolidon S, Seban R, Voisin AL, Pautier P, Romano-Martin P, Even C, Baldini C, Besse B, Albiges L, Boutros C, Routier E, Balleyguier C, De Montpreville VT, Champiat S, Massard C, Robert C, Marabelle A, Mateus C, Lambotte O, Le Pavec J, Michot JM. Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control study. Eur J Cancer 2021;156:46-59. [PMID: 34425404 DOI: 10.1016/j.ejca.2021.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
32 Sekine C, Kawase K, Yoshida K. Sarcoid-like reaction in a HER2-positive breast cancer patient: A case report. Int J Surg Case Rep 2021;85:106280. [PMID: 34393095 DOI: 10.1016/j.ijscr.2021.106280] [Reference Citation Analysis]
33 El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Richard-Colmant G, Weber E, Bert A, Androdias G, Sève P. Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study. Diagnostics (Basel) 2021;11:1240. [PMID: 34359324 DOI: 10.3390/diagnostics11071240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Judson MA. Granulomatous Sarcoidosis Mimics. Front Med (Lausanne) 2021;8:680989. [PMID: 34307411 DOI: 10.3389/fmed.2021.680989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Bonifazi M, Renzoni EA, Lower EE. Sarcoidosis and maligancy: the chicken and the egg? Curr Opin Pulm Med 2021;27:455-62. [PMID: 34231536 DOI: 10.1097/MCP.0000000000000806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Judson MA. A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist. J Clin Med 2021;10:2857. [PMID: 34203188 DOI: 10.3390/jcm10132857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Miedema J, Nunes H. Drug-induced sarcoidosis-like reactions. Curr Opin Pulm Med 2021;27:439-47. [PMID: 34183524 DOI: 10.1097/MCP.0000000000000800] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
38 Armstrong JJ, Zhang R, Fung M, Zeman-Pocrnich C, Rotenberg B, Bauman G, Gilbert K, Hutnik CML. Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis. Am J Ophthalmol Case Rep 2021;23:101132. [PMID: 34151046 DOI: 10.1016/j.ajoc.2021.101132] [Reference Citation Analysis]
39 Itai Y, Ueda Y, Etoh T, Shirasaka Y, Shiroshita H, Shiraishi N, Daa T, Inomata M. Clinical significance of sarcoid-like reaction in lymph nodes of gastric cancer patients. J Surg Oncol 2021;124:293-300. [PMID: 34003494 DOI: 10.1002/jso.26525] [Reference Citation Analysis]
40 Lambert N, Hansen I, El Moussaoui M, Giot JB, Vercheval C, Lommers É, Somja J, Moutschen M, Maquet P. Lung and liver sarcoidosis-like reaction induced by tocilizumab. Br J Clin Pharmacol 2021. [PMID: 33899928 DOI: 10.1111/bcp.14878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Chiang J, Hebroni F, Bedayat A, Pourzand L. Case 286: Sarcoidlike Granulomatosis and Lymphadenopathy-Thoracic Manifestations of Nivolumab Drug Toxicity. Radiology 2021;298:471-5. [PMID: 33493088 DOI: 10.1148/radiol.2021191247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Bauckneht M, Aloè T, Tagliabue E, Cittadini G, Guadagno A, Morbelli S, Barisione E. Beyond Covid-19 vaccination-associated pitfalls on [18F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis. Eur J Nucl Med Mol Imaging 2021;48:2661-2. [PMID: 33876261 DOI: 10.1007/s00259-021-05360-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
43 Vartanov A, Kalotra A, Varughese J, Gautam S, Kandel S, Hosmer W. Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review. Respir Med Case Rep 2021;33:101390. [PMID: 33786301 DOI: 10.1016/j.rmcr.2021.101390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, Boussel L, Calender A, Androdias G, Valeyre D, El Jammal T. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells 2021;10:766. [PMID: 33807303 DOI: 10.3390/cells10040766] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 33.0] [Reference Citation Analysis]
45 Sollena P, Cappilli S, Federico F, Schinzari G, Tortora G, Peris K. "Skin rashes" and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management. Hum Vaccin Immunother 2021;:1-8. [PMID: 33759689 DOI: 10.1080/21645515.2021.1889449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Takemura M, Motegi M, Kuroiwa Y, Itai M, Taguchi K, Umetsu K, Uchida M, Kounoc S, Sato M, Masubuchi H, Yamaguchi A, Yamaguchi K, Ikeda K, Nakagawa J, Maeno T. Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus. Respir Med Case Rep 2021;32:101361. [PMID: 33643837 DOI: 10.1016/j.rmcr.2021.101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Yamaguchi T, Costabel U, McDowell A, Guzman J, Uchida K, Ohashi K, Eishi Y. Immunohistochemical Detection of Potential Microbial Antigens in Granulomas in the Diagnosis of Sarcoidosis. J Clin Med 2021;10:983. [PMID: 33801218 DOI: 10.3390/jcm10050983] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
48 Cadiou S, Robin F, Guillin R, Perdriger A, Jouneau S, Belhomme N, Coiffier G, Guggenbuhl P. Spondyloarthrite et sarcoïdose : faux amis ou véritable association ? Revue systématique de la littérature. Revue du Rhumatisme 2021;88:101-109. [DOI: 10.1016/j.rhum.2021.01.015] [Reference Citation Analysis]
49 Ciccarese F, Piccinino A, Brocchi S, Balacchi C, Dall'Olio FG, Massari F, Rihawi K, Paccapelo A, Ardizzoni A, Golfieri R. Expected and non-expected immune-related adverse events detectable by CT. Eur J Radiol 2021;138:109617. [PMID: 33676358 DOI: 10.1016/j.ejrad.2021.109617] [Reference Citation Analysis]
50 Conti ML, Osaki MH, Sant'Anna AE, Osaki TH. Orbitopalpebral and ocular sarcoidosis: what does the ophthalmologist need to know. Br J Ophthalmol 2021:bjophthalmol-2020-317423. [PMID: 33622698 DOI: 10.1136/bjophthalmol-2020-317423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
51 Sobolewska B, Baglivo E, Edwards AO, Kramer M, Miserocchi E, Palestine AG, Schwab IR, Zamir E, Doycheva D, Zierhut M. Drug-induced Sarcoid Uveitis with Biologics. Ocul Immunol Inflamm 2021;:1-8. [PMID: 33596386 DOI: 10.1080/09273948.2020.1850799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Obi ON, Lower EE, Baughman RP. Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Rev Clin Pharmacol 2021;14:179-210. [PMID: 33487042 DOI: 10.1080/17512433.2021.1878024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
53 González-Cruz C, Bodet D, Muñoz-Couselo E, García-Patos V. Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab. BMJ Case Rep 2021;14:e237310. [PMID: 33509865 DOI: 10.1136/bcr-2020-237310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Hatipoglu D, Tanski C, Hachamovitch R, Legha S, Moudgil R. Ixekizumab-Induced Cardiac Sarcoidosis: A Case Report. CJC Open 2021;3:118-20. [PMID: 33458639 DOI: 10.1016/j.cjco.2020.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
55 Torres-Jiménez J, Esteban-Villarrubia J, García-Abellás P, Cortés-Salgado A, Soria-Rivas A, Gajate-Borau P, Olmedo-García ME, Corral-de la Fuente E, Lage-Alfranca Y, Gómez-Rueda A, Benito-Berlinches A, Gorospe-Sarasua L, Garrido-López P. Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital. Clin Transl Oncol 2021;23:1474-80. [PMID: 33433837 DOI: 10.1007/s12094-020-02546-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
56 Narula N, Iannuzzi M. Sarcoidosis: Pitfalls and Challenging Mimickers. Front Med (Lausanne) 2020;7:594275. [PMID: 33505980 DOI: 10.3389/fmed.2020.594275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
57 Pundole X, Ramos-casals M, Lambotte O. Sarcoidosis. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy 2021. [DOI: 10.1007/978-3-030-56824-5_8] [Reference Citation Analysis]
58 Jameson A, Revels J, Wang LL, Wang DT, Wang SS. Sarcoidosis, the master mimicker. Curr Probl Diagn Radiol 2020:S0363-0188(20)30197-3. [PMID: 33308891 DOI: 10.1067/j.cpradiol.2020.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol 2020;11:545413. [PMID: 33329511 DOI: 10.3389/fimmu.2020.545413] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
60 Thiruchelvam N, Rajasurya V, Tharmendira S, Torbic H, Waldron M, Stoller JK, Culver DA. Immune-related Pulmonary Toxicity From Cancer Immunotherapy: A Systematic Approach. Clinical Pulmonary Medicine 2020;27:183-192. [DOI: 10.1097/cpm.0000000000000383] [Reference Citation Analysis]
61 Sawahata M, Fujiki Y, Nakano N, Ohtsuki M, Yamaguchi T, Uchida K, Eishi Y, Suzuki T, Hagiwara K, Bando M. Propionibacterium acnes-associated Sarcoidosis Possibly Initially Triggered by Interferon-alpha Therapy. Intern Med 2021;60:777-81. [PMID: 32999227 DOI: 10.2169/internalmedicine.5281-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Aedma SK, Chidharla A, Kelting S, Kasi A. Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer. BMJ Case Rep 2020;13:e229548. [PMID: 32907862 DOI: 10.1136/bcr-2019-229548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Chopra A, Avadhani V, Tiwari A, Riemer EC, Sica G, Judson MA. Granulomatous lung disease: clinical aspects. Expert Rev Respir Med 2020;14:1045-63. [PMID: 32662705 DOI: 10.1080/17476348.2020.1794827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Cunningham ET, Moorthy RS, Zierhut M. Immune Checkpoint Inhibitor-Induced Uveitis. Ocular Immunology and Inflammation 2020;28:847-9. [DOI: 10.1080/09273948.2020.1801286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
65 Yeung SJ, Qdaisat A, Chaftari P, Lipe D, Merlin J, Rajha E, Wechsler A, Sandoval M, Viets J, Al-Breiki A, Shah M, Pandey R, Kamal M, Khattab O, Toale K, Wattana M, Elsayem A, Gaeta S, Brock P, Reyes-Gibby C, Alagappan K. Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department. J Am Coll Emerg Physicians Open 2020;1:1637-59. [PMID: 33392573 DOI: 10.1002/emp2.12209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
66 James WE. Overlap Syndromes in Sarcoidosis: Clinical Features and Outcomes. Semin Respir Crit Care Med 2020;41:607-17. [PMID: 32777847 DOI: 10.1055/s-0040-1713008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Lee GM, Walker CM. Reply to “Pulmonary Sarcoidlike Granulomatosis”. American Journal of Roentgenology 2020;215:W26-W26. [DOI: 10.2214/ajr.20.22940] [Reference Citation Analysis]
68 Okada H, Ouchi K, Saito T, Takahashi Y, Yamada M, Negami N, Ishido Y, Yamazaki S, Sato M. Splenic sarcoid reaction mimicking metachronous metastasis in patients after distal gastrectomy for gastric cancer: a case report and literature review. Surg Case Rep 2020;6:185. [PMID: 32728980 DOI: 10.1186/s40792-020-00955-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Cadiou S, Robin F, Guillin R, Perdriger A, Jouneau S, Belhomme N, Coiffier G, Guggenbuhl P. Spondyloarthritis and sarcoidosis: Related or fake friends? A systematic literature review. Joint Bone Spine 2020;87:579-87. [PMID: 32622038 DOI: 10.1016/j.jbspin.2020.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
70 Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020;201:e26-51. [PMID: 32293205 DOI: 10.1164/rccm.202002-0251ST] [Cited by in Crossref: 243] [Cited by in F6Publishing: 272] [Article Influence: 121.5] [Reference Citation Analysis]
71 Langan EA, Graetz V, Allerheiligen J, Zillikens D, Rupp J, Terheyden P. Immune checkpoint inhibitors and tuberculosis: an old disease in a new context. Lancet Oncol 2020;21:e55-65. [PMID: 31908308 DOI: 10.1016/S1470-2045(19)30674-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
72 Gorospe L, Pacios-blanco RE, Garrido-lópez P. The Importance of Imaging Studies in the Assessment of Response to Immunotherapy in Lung Cancer. Archivos de Bronconeumología (English Edition) 2020;56:380-389. [DOI: 10.1016/j.arbr.2020.04.003] [Reference Citation Analysis]
73 Frye BC, Rump IC, Uhlmann A, Schubach F, Ihorst G, Grimbacher B, Zissel G, Quernheim JM. Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial. Contemp Clin Trials Commun 2020;19:100575. [PMID: 32551397 DOI: 10.1016/j.conctc.2020.100575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
74 Melissaropoulos K, Klavdianou K, Filippopoulou A, Kalofonou F, Kalofonos H, Daoussis D. Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors. Int J Mol Sci 2020;21:E3389. [PMID: 32403289 DOI: 10.3390/ijms21093389] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
75 Koda K, Toyoshima M, Nozue T, Suda T. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature. Intern Med 2020;59:2015-21. [PMID: 32389943 DOI: 10.2169/internalmedicine.4275-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
76 El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Valeyre D, Sève P. Refractory Sarcoidosis: A Review. Ther Clin Risk Manag 2020;16:323-45. [PMID: 32368072 DOI: 10.2147/TCRM.S192922] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
77 Stoffaës L, Dumazet A, Deslee G, Mohammad Muttaqi Z, Didier K, Botsen D. Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report. Breast J 2020;26:1239-41. [PMID: 32275106 DOI: 10.1111/tbj.13800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Chorti E, Kanaki T, Zimmer L, Hadaschik E, Ugurel S, Gratsias E, Roesch A, Bonella F, Wessendorf TE, Wälscher J, Theegarten D, Schadendorf D, Livingstone E. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis. Eur J Cancer 2020;131:18-26. [PMID: 32248071 DOI: 10.1016/j.ejca.2020.02.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
79 Flory V, Chardin D, Occelli A, Benois A, Brunner P, Cucchi J, Perrin C, Baqué-juston M. La sarcoïdose pour les nuls… et plus si affinités ! Journal d'imagerie diagnostique et interventionnelle 2020;3:36-46. [DOI: 10.1016/j.jidi.2019.11.001] [Reference Citation Analysis]
80 Belhomme N, Gaignon T, Jouneau S, Misery L, Abasq-Thomas C, Cador B, Lecureur V, Cadiou S, Ballerie A, Polard E, Mensi S, Jego P, Lescoat A. Drug-induced granulomatosis: is dupilumab the new kid on the block? J Eur Acad Dermatol Venereol 2020;34:e312-3. [PMID: 31958359 DOI: 10.1111/jdv.16218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Gorospe L, Pacios-Blanco RE, Garrido-López P. The Importance of Imaging Studies in the Assessment of Response to Immunotherapy in Lung Cancer. Arch Bronconeumol (Engl Ed) 2020;56:380-9. [PMID: 31898993 DOI: 10.1016/j.arbres.2019.10.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yserbyt J, Wells AU. Sarcoidosis: pulmonary manifestations and management. In: Wuyts WA, Cottin V, Spagnolo P, Wells AU, editors. Pulmonary Manifestations of Systemic Diseases. Sheffield: European Respiratory Society; 2019. pp. 404-18. [DOI: 10.1183/2312508x.10015919] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Judson MA. The epidemic of drug-induced sarcoidosis-like reactions: a side effect that we can live with. J Intern Med 2020;288:373-5. [PMID: 31724232 DOI: 10.1111/joim.13008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
84 Cohen Aubart F, Lhote R, Amoura A, Valeyre D, Haroche J, Amoura Z, Lebrun-Vignes B. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med 2020;288:356-62. [PMID: 31612562 DOI: 10.1111/joim.12991] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
85 Marcotte ME, Panet F, Croteau E, Richard MA, Pavic M, Levasseur MA. Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture. Eur J Nucl Med Mol Imaging 2019;46:2402-3. [PMID: 31309258 DOI: 10.1007/s00259-019-04412-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers 2019;5:45. [PMID: 31273209 DOI: 10.1038/s41572-019-0096-x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 178] [Article Influence: 57.7] [Reference Citation Analysis]
87 Lafon M, Blaye C, Kind M, Bechade D, Chassaigne F, Italiano A, Grellety T. Sarcoidosis-like reaction in metastatic triple negative breast cancer treated by anti-PD-L1. Breast J 2019;25:971-3. [PMID: 31165561 DOI: 10.1111/tbj.13386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
88 Durcan R, Heffron C, Sweeney B. Natalizumab induced cutaneous sarcoidosis-like reaction. J Neuroimmunol 2019;333:476955. [PMID: 31108403 DOI: 10.1016/j.jneuroim.2019.04.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
89 Iftikhar A, Cheema MAI, Ramachandran P, Sahni S. Sarcoid-like reaction associated with renal cell carcinoma - A case report. Respir Med Case Rep 2019;27:100847. [PMID: 31024794 DOI: 10.1016/j.rmcr.2019.100847] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Gade Sikjær M, Hilberg O, Ibsen R, Bock K, Løkke A. Direct and indirect economic and health consequences related to sarcoidosis in Denmark: A national register-based study. Respir Med 2019;152:7-13. [PMID: 31128613 DOI: 10.1016/j.rmed.2019.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
91 Trisolini R, Baughman RP, Spagnolo P, Culver DA. Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: Beyond the diagnostic yield. Respirology 2019;24:531-42. [PMID: 30912244 DOI: 10.1111/resp.13537] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
92 Llanos O, Hamzeh N. Sarcoidosis. Med Clin North Am 2019;103:527-34. [PMID: 30955519 DOI: 10.1016/j.mcna.2018.12.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
93 Judson MA, Elicker BM, Colby TV, Kwon S, de Windt E, Chalkias S, Prada C, Smirnakis K, Singhal P. The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials. Respir Med 2019;149:23-7. [PMID: 30885425 DOI: 10.1016/j.rmed.2019.01.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
94 Isshiki T, Matsuyama H, Sakamoto S, Honma N, Mikami T, Shibuya K, Eishi Y, Homma S. Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy. Intern Med 2019;58:1473-7. [PMID: 30626837 DOI: 10.2169/internalmedicine.2086-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
95 Imadojemu S, Rosenbach M. Advances in Inflammatory Granulomatous Skin Diseases. Dermatologic Clinics 2019;37:49-64. [DOI: 10.1016/j.det.2018.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
96 Yserbyt J, Wuyts W. Baughman’s Sarcoidosis. Sarcoidosis 2019. [DOI: 10.1016/b978-0-323-54429-0.00007-0] [Reference Citation Analysis]
97 Akella P, Loganathan S, Jindal V, Akhtar J, Lal A. Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series. Respir Med Case Rep 2019;26:17-22. [PMID: 30456167 DOI: 10.1016/j.rmcr.2018.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]